中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 1
Jan.  2019
Turn off MathJax
Article Contents

Etiological diagnosis and standard treatment of portal hypertension should be taken seriously

DOI: 10.3969/j.issn.1001-5256.2019.01.001
  • Received Date: 2018-12-19
  • Published Date: 2019-01-20
  • Portal hypertension (PH) referes to an abnormal increase in portal venous pressure due to increased resistance and/or blood flow of the portal vein or backflow obstruction of the hepatic veins and often manifests as splenomegaly, hypersplenism, gastroesophageal varices and bleeding, ascites, and hepatic encephalopathy.Liver synthetic dysfunction is often seen in sinusoidal PH caused by liver cirrhosis, while it is less often seen in pre-hepatic/pre-sinusoidal PH due to abnormalities in the extrahepatic and intrahepatic portal veins or posthepatic/post-sinusoidal PH due to backflow obstruction of the extrahepatic and intrahepatic hepatic veins.The presence or absence of PH can be determined by clinical symptoms, signs, and hematological parameters, and type and etiology can be clarified by imaging examinations, hepatic venous pressure gradient, and histopathological features.In addition to the active treatment of primary diseases, nonselective beta-blockers, endoscopy, and interventional or surgical therapy should be used for the prevention and treatment of PH complications.

     

  • loading
  • [1]GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:Risk stratification, diagnosis, and management:2016 practice guidance by the A-merican Association for the study of liver diseases[J].Hepatology, 2017, 65 (1) :310-335.
    [2]de FRANCHIS R.Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752.
    [3]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Endoscopy, Chinese Medical Association.Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
    [4]European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Vascular diseases of the liver[J].J Hepatol, 2016, 64 (1) :179-202.
    [5]MARTNLLAHM, ALBILLOS A, BAARES R, et al.Vascular diseases of the liver.Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver[J].Gastroenterol Hepatol, 2017, 40 (8) :538-580.
    [6]KHANNA R, SARIN SK.Idiopathic portal hypertension and extrahepatic portal venous obstruction[J].Hepatol Int, 2018, 12 (Suppl 1) :148-167.
    [7]THOMPSON RJ, TAYLOR MA, MCKIE LD, et al.Sinistral portal hypertension[J].Ulster Med J, 2006, 75 (3) :175-177.
    [8]BOSCH J, ABRALDES JG, BERZIGOTTI A, et al.The clinical use of HVPG measurements in chronic liver disease[J].Nat Rev Gastroenterol Hepatol, 2009, 6 (10) :573-582.
    [9]BOSCH J, IWAKIRI Y.The portal hypertension syndrome:Etiology, classification, relevance, and animal models[J].Hepatol Int, 2018, 12 (Suppl 1) :1-10.
    [10]ZHANG M, ZHUGE YZ, ZOU XP.Application of interventional techniques in patients with unknown etiologic portal hypertension[J].JPrac Hepatol, 2018, 21 (3) :329-331. (in Chinese) 张明, 诸葛宇征, 邹晓平.介入技术在不明原因的门脉高压症诊治中的应用[J].实用肝脏病杂志, 2018, 21 (3) :329-331.
    [11]ABRALDES JG, SARLIEVE P, TANDON P.Measurement of portal pressure[J].Clin Liver Dis, 2014, 18 (4) :779-792.
    [12]KHANNA R, SARIN SK.Non-cirrhotic portal hypertensiondiagnosis and management[J].J Hepatol, 2014, 60 (2) :421-441.
    [13]RAJESH S, MUKUND A, SUREKA B, et al.Non-cirrhotic portal hypertension:An imaging review[J].Abdom Radiol (NY) , 2018, 43 (8) :1991-2010.
    [14]SAHIN A, ARTAS H, TUNC N, et al.Hematological indices in portal hypertension:Cirrhosis versus noncirrhotic portal hypertension[J].J Clin Med, 2018, 7 (8) :196.
    [15]LIU F, NING Z, LIU Y, et al.Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701) :A prospective multicenter study[J].EBio Medicine, 2018, 36:151-158.
    [16]TSENG Y, MA L, LUO T, et al.Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology[J].Exp T-her Med, 2018, 15 (4) :3329-3335.
    [17]SHIHA G, IBRAHIM A, HELMY A, et al.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis:A 2016 update[J].Hepatol Int, 2017, 11 (1) :1-30.
    [18]QI X, BERZIGOTTI A, CARDENAS A, et al.Emerging noninvasive approaches for diagnosis and monitoring of portal hypertension[J].Lancet Gastroenterol Hepatol, 2018, 3 (10) :708-719.
    [19]ZHANG J, CHEN MK.Progress of diagnosis and treatment of portal hypertension[J].Chin J Gastroenterol Hepatol, 2018, 27 (3) :341-345. (in Chinese) 张静, 陈明锴.门脉高压症的诊断与治疗进展[J].胃肠病学和肝病学杂志, 2018, 27 (3) :341-345.
    [20]QI X.Virtual portal pressure gradient from anatomic CT angiography[J].Gut, 2015, 64 (6) :1004-1005.
    [21]GIOIA S, NARDELLI S, PASQUALE C, et al.Natural history of patients with non cirrhotic portal hypertension:Comparison with patients with compensated cirrhosis[J].Dig Liver Dis, 2018, 50 (8) :839-844.
    [22]Chinese Portal Hypertension Diagnosis and Monitoring Study Group (Chess) ;Minimally Invasive Intervention Collaborative Group, Chinese Society of Gastroenterology;Emergency Intervention Committee, Chinese Society of Interventionalists, et al.Consensus on clinical applictation of hepatic venous pressure gradient in China (2018) [J].J Clin Hepatol, 2018, 34 (12) :2526-2536. (in Chinese) 中国门静脉高压诊断与监测研究组 (CHESS) , 中华医学会消化病学分会微创介入协作组, 中国医师协会介入医师分会急诊介入专业委员会, 等.中国肝静脉压力梯度临床应用专家共识 (2018版) [J].临床肝胆病杂志, 2018, 34 (12) :2526-2536.
    [23]CHEN SY, HUANG XQ, CENG XQ.Etiology and diagnosis of portal hypertension[J].J Pract Hepatol, 2018, 21 (3) :321-324. (in Chinese) 陈世耀, 黄晓铨, 曾晓清.门脉高压症的检查选择与病因诊断[J].实用肝脏病杂志, 2018, 21 (3) :321-324.
    [24]TRIPATHI D, STANLEY AJ, HAYES PC, et al.UK guidelines on the management of variceal haemorrhage in cirrhotic patients[J].Gut, 2015, 64 (11) :1680-1704.
    [25] GARCA-PAGN JC, CACA K, BUREAU C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].NEngl J Med, 2010, 153 (10) :2370-2379.
    [26]SAUERBRUCH T, SCHIERWAGEN R, TREBICKA J.Managing portal hypertension in patients with liver cirrhosis[J].F1000Res, 2018, 7:533.
    [27]SCHWABL P, LALEMAN W.Novel treatment options for portal hypertension[J].Gastroenterol Rep, 2017, 5 (2) :90-103.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1803) PDF downloads(539) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return